Annual report pursuant to Section 13 and 15(d)

Shareholders' Equity (Deficit) and Temporary Equity

v3.3.1.900
Shareholders' Equity (Deficit) and Temporary Equity
 12 Months Ended
Dec. 31, 2015
Shareholders' Equity (Deficit) and Temporary Equity  
Shareholders’ Equity (Deficit) and Temporary Equity

8.Shareholders’ Equity (Deficit) and Temporary Equity

 

AxoGen, Inc. Classes of Stock

 

AxoGen, Inc.’s authorized capital stock consists of 50,000,000 shares of common stock, par value $0.01 per share. The authorized capital stock is divisible into the classes and series, has the designation, voting rights, and other rights and preferences and is subject to the restrictions that the AxoGen Board of Directors may from time to time establish. Unless otherwise designated by the AxoGen Board of Directors, all shares are common stock. AxoGen has not designated any shares other than common stock.

 

Warrants

 

Pursuant to a retired financing agreement, certain lenders received a ten-year warrant to purchase 89,686 shares of AxoGen’s common stock at $2.23 per share.  The warrants have an effective date of September 30, 2011.  On November 13, 2015, 44,843 of these warrants were exercised in a cashless exchange resulting in 25,903 shares being issued to the warrant holder.